Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eurofins Ntd Llc |
RCV000082279 | SCV000114228 | benign | not specified | 2013-04-30 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV001647065 | SCV001855802 | benign | not provided | 2020-12-04 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001647065 | SCV002334753 | benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002371931 | SCV002692245 | likely benign | Inborn genetic diseases | 2017-06-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Genetic Services Laboratory, |
RCV000082279 | SCV003839943 | benign | not specified | 2022-11-06 | no assertion criteria provided | clinical testing | |
| Prevention |
RCV003915102 | SCV004736461 | likely benign | RAI1-related disorder | 2019-08-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |